These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Malaria-specific and nonspecific activation of CD8+ T cells during blood stage of Plasmodium berghei infection. Miyakoda M; Kimura D; Yuda M; Chinzei Y; Shibata Y; Honma K; Yui K J Immunol; 2008 Jul; 181(2):1420-8. PubMed ID: 18606696 [TBL] [Abstract][Full Text] [Related]
10. Prevention of experimental cerebral malaria by Flt3 ligand during infection with Plasmodium berghei ANKA. Tamura T; Kimura K; Yuda M; Yui K Infect Immun; 2011 Oct; 79(10):3947-56. PubMed ID: 21807908 [TBL] [Abstract][Full Text] [Related]
11. Eosinophils Suppress the Migration of T Cells Into the Brain of Scheunemann JF; Reichwald JJ; Korir PJ; Kuehlwein JM; Jenster LM; Hammerschmidt-Kamper C; Lewis MD; Klocke K; Borsche M; Schwendt KE; Soun C; Thiebes S; Limmer A; Engel DR; Mueller AK; Hoerauf A; Hübner MP; Schumak B Front Immunol; 2021; 12():711876. PubMed ID: 34659202 [TBL] [Abstract][Full Text] [Related]
12. IFN-γ-producing CD4+ T cells promote experimental cerebral malaria by modulating CD8+ T cell accumulation within the brain. Villegas-Mendez A; Greig R; Shaw TN; de Souza JB; Gwyer Findlay E; Stumhofer JS; Hafalla JC; Blount DG; Hunter CA; Riley EM; Couper KN J Immunol; 2012 Jul; 189(2):968-79. PubMed ID: 22723523 [TBL] [Abstract][Full Text] [Related]
13. Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria. Campanella GS; Tager AM; El Khoury JK; Thomas SY; Abrazinski TA; Manice LA; Colvin RA; Luster AD Proc Natl Acad Sci U S A; 2008 Mar; 105(12):4814-9. PubMed ID: 18347328 [TBL] [Abstract][Full Text] [Related]
14. Control of pathogenic CD8+ T cell migration to the brain by IFN-gamma during experimental cerebral malaria. Belnoue E; Potter SM; Rosa DS; Mauduit M; Grüner AC; Kayibanda M; Mitchell AJ; Hunt NH; Rénia L Parasite Immunol; 2008 Oct; 30(10):544-53. PubMed ID: 18665903 [TBL] [Abstract][Full Text] [Related]
15. CD4+ CD25+ regulatory T cells suppress CD4+ T-cell function and inhibit the development of Plasmodium berghei-specific TH1 responses involved in cerebral malaria pathogenesis. Nie CQ; Bernard NJ; Schofield L; Hansen DS Infect Immun; 2007 May; 75(5):2275-82. PubMed ID: 17325053 [TBL] [Abstract][Full Text] [Related]
16. Infection-Induced Resistance to Experimental Cerebral Malaria Is Dependent Upon Secreted Antibody-Mediated Inhibition of Pathogenic CD8 Shaw TN; Inkson CA; Villegas-Mendez A; Pattinson DJ; Strangward P; Else KJ; Draper SJ; Zeef LAH; Couper KN Front Immunol; 2019; 10():248. PubMed ID: 30846985 [TBL] [Abstract][Full Text] [Related]
17. IRGM3 contributes to immunopathology and is required for differentiation of antigen-specific effector CD8+ T cells in experimental cerebral malaria. Guo J; McQuillan JA; Yau B; Tullo GS; Long CA; Bertolino P; Roediger B; Weninger W; Taylor GA; Hunt NH; Ball HJ; Mitchell AJ Infect Immun; 2015 Apr; 83(4):1406-17. PubMed ID: 25644000 [TBL] [Abstract][Full Text] [Related]